vs

Side-by-side financial comparison of Canterbury Park Holding Corp (CPHC) and CHAMPIONS ONCOLOGY, INC. (CSBR). Click either name above to swap in a different company.

CHAMPIONS ONCOLOGY, INC. is the larger business by last-quarter revenue ($15.0M vs $12.4M, roughly 1.2× Canterbury Park Holding Corp). CHAMPIONS ONCOLOGY, INC. runs the higher net margin — 1.8% vs -3.1%, a 4.9% gap on every dollar of revenue. On growth, CHAMPIONS ONCOLOGY, INC. posted the faster year-over-year revenue change (11.5% vs 3.9%). Canterbury Park Holding Corp produced more free cash flow last quarter ($-611.3K vs $-2.0M). Over the past eight quarters, CHAMPIONS ONCOLOGY, INC.'s revenue compounded faster (11.8% CAGR vs -6.0%).

Canterbury Park, is a horse racing track in Shakopee, Minnesota, United States. Canterbury Park Holding Corporation hosts parimutuel wagering on live thoroughbred and quarter horse racing at its facilities in Shakopee and parimutuel wagering on races held at out-of-state racetracks that are simulcast to the racetrack. In addition, the Canterbury Park Card Casino operates 24 hours a day, seven days a week, and is also regulated by the Minnesota Racing Commission. Casino games include blackjack...

Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist.

CPHC vs CSBR — Head-to-Head

Bigger by revenue
CSBR
CSBR
1.2× larger
CSBR
$15.0M
$12.4M
CPHC
Growing faster (revenue YoY)
CSBR
CSBR
+7.6% gap
CSBR
11.5%
3.9%
CPHC
Higher net margin
CSBR
CSBR
4.9% more per $
CSBR
1.8%
-3.1%
CPHC
More free cash flow
CPHC
CPHC
$1.4M more FCF
CPHC
$-611.3K
$-2.0M
CSBR
Faster 2-yr revenue CAGR
CSBR
CSBR
Annualised
CSBR
11.8%
-6.0%
CPHC

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
CPHC
CPHC
CSBR
CSBR
Revenue
$12.4M
$15.0M
Net Profit
$-390.1K
$268.0K
Gross Margin
51.7%
Operating Margin
2.6%
1.2%
Net Margin
-3.1%
1.8%
Revenue YoY
3.9%
11.5%
Net Profit YoY
68.7%
-63.2%
EPS (diluted)
$-0.08
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CPHC
CPHC
CSBR
CSBR
Q4 25
$12.4M
$15.0M
Q3 25
$18.3M
$14.0M
Q2 25
$15.7M
$12.4M
Q1 25
$13.1M
$17.0M
Q4 24
$12.0M
$13.5M
Q3 24
$19.3M
$14.1M
Q2 24
$16.2M
$14.0M
Q1 24
$14.1M
$12.0M
Net Profit
CPHC
CPHC
CSBR
CSBR
Q4 25
$-390.1K
$268.0K
Q3 25
$487.3K
$-436.0K
Q2 25
$-327.4K
$-1.8M
Q1 25
$-299.2K
$4.5M
Q4 24
$-1.2M
$728.0K
Q3 24
$2.0M
$1.3M
Q2 24
$338.3K
$-109.0K
Q1 24
$998.2K
$-2.5M
Gross Margin
CPHC
CPHC
CSBR
CSBR
Q4 25
51.7%
Q3 25
42.9%
Q2 25
41.1%
Q1 25
61.2%
Q4 24
44.9%
Q3 24
49.7%
Q2 24
48.2%
Q1 24
34.7%
Operating Margin
CPHC
CPHC
CSBR
CSBR
Q4 25
2.6%
1.2%
Q3 25
5.7%
-3.8%
Q2 25
2.8%
-16.2%
Q1 25
4.9%
26.4%
Q4 24
-0.8%
5.4%
Q3 24
18.9%
9.5%
Q2 24
6.9%
-1.9%
Q1 24
12.5%
-21.4%
Net Margin
CPHC
CPHC
CSBR
CSBR
Q4 25
-3.1%
1.8%
Q3 25
2.7%
-3.1%
Q2 25
-2.1%
-14.9%
Q1 25
-2.3%
26.4%
Q4 24
-10.4%
5.4%
Q3 24
10.5%
9.3%
Q2 24
2.1%
-0.8%
Q1 24
7.1%
-21.1%
EPS (diluted)
CPHC
CPHC
CSBR
CSBR
Q4 25
$-0.08
$0.02
Q3 25
$0.10
$-0.03
Q2 25
$-0.06
$-0.12
Q1 25
$-0.06
$0.31
Q4 24
$-0.25
$0.05
Q3 24
$0.40
$0.09
Q2 24
$0.07
$-0.01
Q1 24
$0.20
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CPHC
CPHC
CSBR
CSBR
Cash + ST InvestmentsLiquidity on hand
$17.1M
$8.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$83.9M
$4.2M
Total Assets
$112.6M
$30.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CPHC
CPHC
CSBR
CSBR
Q4 25
$17.1M
$8.5M
Q3 25
$16.7M
$10.3M
Q2 25
$16.9M
$9.8M
Q1 25
$15.4M
$3.2M
Q4 24
$15.1M
$2.8M
Q3 24
$21.7M
$2.9M
Q2 24
$23.8M
$2.6M
Q1 24
$25.2M
$4.5M
Stockholders' Equity
CPHC
CPHC
CSBR
CSBR
Q4 25
$83.9M
$4.2M
Q3 25
$84.1M
$3.5M
Q2 25
$83.6M
$3.8M
Q1 25
$83.7M
$5.5M
Q4 24
$84.1M
$681.0K
Q3 24
$85.2M
$-332.0K
Q2 24
$83.2M
$-1.9M
Q1 24
$82.7M
$-2.1M
Total Assets
CPHC
CPHC
CSBR
CSBR
Q4 25
$112.6M
$30.2M
Q3 25
$114.4M
$30.5M
Q2 25
$114.9M
$32.3M
Q1 25
$112.4M
$30.6M
Q4 24
$109.9M
$25.2M
Q3 24
$114.2M
$24.9M
Q2 24
$111.4M
$26.1M
Q1 24
$105.6M
$26.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CPHC
CPHC
CSBR
CSBR
Operating Cash FlowLast quarter
$-103.4K
$-1.7M
Free Cash FlowOCF − Capex
$-611.3K
$-2.0M
FCF MarginFCF / Revenue
-4.9%
-13.1%
Capex IntensityCapex / Revenue
4.1%
1.6%
Cash ConversionOCF / Net Profit
-6.47×
TTM Free Cash FlowTrailing 4 quarters
$4.7M
$5.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CPHC
CPHC
CSBR
CSBR
Q4 25
$-103.4K
$-1.7M
Q3 25
$1.2M
$600.0K
Q2 25
$4.4M
$6.9M
Q1 25
$3.4M
$490.0K
Q4 24
$-2.8M
$-283.0K
Q3 24
$2.3M
$311.0K
Q2 24
$5.4M
$-1.8M
Q1 24
$1.6M
$-919.0K
Free Cash Flow
CPHC
CPHC
CSBR
CSBR
Q4 25
$-611.3K
$-2.0M
Q3 25
$-395.3K
$554.0K
Q2 25
$3.2M
$6.6M
Q1 25
$2.5M
$448.0K
Q4 24
$-6.7M
$-377.0K
Q3 24
$-25
Q2 24
$1.8M
$-1.8M
Q1 24
$-601.0K
$-1.0M
FCF Margin
CPHC
CPHC
CSBR
CSBR
Q4 25
-4.9%
-13.1%
Q3 25
-2.2%
4.0%
Q2 25
20.5%
53.5%
Q1 25
19.1%
2.6%
Q4 24
-55.9%
-2.8%
Q3 24
-0.0%
Q2 24
11.1%
-13.0%
Q1 24
-4.3%
-8.4%
Capex Intensity
CPHC
CPHC
CSBR
CSBR
Q4 25
4.1%
1.6%
Q3 25
9.0%
0.3%
Q2 25
7.5%
2.0%
Q1 25
6.5%
0.2%
Q4 24
32.6%
0.7%
Q3 24
11.8%
0.0%
Q2 24
22.2%
0.0%
Q1 24
15.7%
0.8%
Cash Conversion
CPHC
CPHC
CSBR
CSBR
Q4 25
-6.47×
Q3 25
2.56×
Q2 25
Q1 25
0.11×
Q4 24
-0.39×
Q3 24
1.12×
0.24×
Q2 24
15.95×
Q1 24
1.62×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CPHC
CPHC

Casino$9.5M76%
Other$1.9M15%
Food And Beverage$1.0M8%

CSBR
CSBR

Pharmacology Services$14.5M97%
Other$520.0K3%

Related Comparisons